Product Information
BUPIVACAINE 0.5% VIAL is a generic product labeled by Xellia Pharmaceuticals USA LLC, priced at $0.0860 per ML under NDC 70594011901. Its NADAC has been published 84 times since Nov 20, 2024.
Strength
5 mg/mL
Manufacturer
Xellia Pharmaceuticals USA LLCNDC
70594011901
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
PERINEURAL
Last Updated
4/22/2026
Active Ingredients
BUPIVACAINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA091503On Market Since
8/1/2023
Pharmacological Classes
Price Statistics
The NADAC for BUPIVACAINE 0.5% VIAL has been published 84 times since Nov 20, 2024, and over the history we have for it it has risen 17.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0860 per ML |
|---|---|
| All-time high | $0.0860 (Jun 24, 2026) |
| All-time low | $0.0701 (Mar 19, 2025) |
| 52-week high | $0.0860 |
| 52-week low | $0.0750 |
| Median price | $0.0778 |
| Average price | $0.0782 |
| Largest weekly change | +6.8% (Jun 18, 2025) |
| Weeks tracked | 84 |
| Tracking since | Nov 20, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Bupivacaine Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of BUPIVACAINE 0.5% VIAL?
The current National Average Drug Acquisition Cost (NADAC) for BUPIVACAINE 0.5% VIAL, manufactured by Xellia Pharmaceuticals USA LLC, is $0.0860 per ML (NDC 70594011901), effective Jun 24, 2026.
How has the price of BUPIVACAINE 0.5% VIAL changed over time?
Over the history we have for it, the NADAC for BUPIVACAINE 0.5% VIAL has risen 17.0%. It has been tracked across 84 weekly CMS publications since Nov 20, 2024.
What are the highest and lowest recorded NADAC prices for BUPIVACAINE 0.5% VIAL?
Since Nov 20, 2024, the NADAC for BUPIVACAINE 0.5% VIAL has ranged from a low of $0.0701 (Mar 19, 2025) to a high of $0.0860 (Jun 24, 2026), with a median of $0.0778 per ML.
Are there cheaper alternatives to BUPIVACAINE 0.5% VIAL?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of BUPIVACAINE 0.5% VIAL, so no direct lower-cost alternative is listed.
Who manufactures BUPIVACAINE 0.5% VIAL?
BUPIVACAINE 0.5% VIAL (NDC 70594011901) is labeled by Xellia Pharmaceuticals USA LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification